4DMedical Limited (4DX.AX)
AUD 0.46
(1.11%)
AUD 0.46
(1.11%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 3.75 Million | 282.18 Thousand | 1.05 Million | 216.97 Thousand | 1.23 Million | 695 Thousand |
| Cost of Revenue | 236.71 Thousand | 34.14 Thousand | 773.68 Thousand | 91.85 Thousand | 9.36 Million | 4.42 Million |
| Gross Profit | 3.51 Million | 248.03 Thousand | 280.61 Thousand | 125.12 Thousand | -8.13 Million | -3.72 Million |
| Operating Expenses | 31.48 Million | 45.25 Million | 37.03 Million | 24.46 Million | 7.82 Million | 3.29 Million |
| Selling, General and Administrative Expenses | 30.16 Million | 25.11 Million | 21.12 Million | 12.7 Million | 4.3 Million | 3.29 Million |
| Research and Development Expenses | 3.65 Million | 4.03 Million | 4.44 Million | 2.35 Million | 3.52 Million | 2.28 Million |
| Other Expenses | - | 13.55 Million | 12.28 Million | 5.59 Million | - | - |
| Cost and Expenses | 31.72 Million | 45.28 Million | 37.8 Million | 24.55 Million | 17.19 Million | 7.71 Million |
| Operating Income | -27.96 Million | -31.13 Million | -36.75 Million | -18.77 Million | -15.96 Million | -7.01 Million |
| Interest Expense | 263.96 Thousand | 6502.00 | 179.55 Thousand | 2.62 Million | 8.01 Million | 300.26 Thousand |
| Income Tax Expense | -4.41 Million | 323.22 Thousand | 43.2 Thousand | 15.3 Thousand | -817.96 Thousand | -650.6 Thousand |
| Earnings before Tax | -40.39 Million | -31.13 Million | -24.54 Million | -21.4 Million | -22.79 Million | -7.14 Million |
| Net Income | -35.97 Million | -31.45 Million | -24.59 Million | -21.42 Million | -21.97 Million | -6.49 Million |
| Earnings Per Share Basic | -0.11 | -0.10 | -0.08 | -0.08 | -0.08 | -0.04 |
| Earnings Per Share Diluted | -0.11 | -0.10 | -0.08 | -0.08 | -0.08 | -0.04 |
| Weighted Average Shares Outstanding | 327.07 Million | 300.01 Million | 294.5 Million | 261.41 Million | 264.76 Million | 151.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 327.07 Million | 300.01 Million | 294.5 Million | 261.41 Million | 264.76 Million | 151.82 Million |
| Gross Margin | 0.94 | 0.88 | 0.27 | 0.58 | -6.60 | -5.36 |
| EBIT Margin | -9.61 | -101.23 | -33.44 | -83.13 | -12.48 | -9.95 |
| Profit Margin | -9.58 | -111.49 | -23.33 | -98.72 | -17.83 | -9.34 |
| EBITDA | -36.06 Million | -33.74 Million | -36.34 Million | -18.03 Million | -15.76 Million | -6.73 Million |
| Earnings Before Tax Margin | -7.45 | -110.32 | -34.86 | -86.54 | -12.95 | -10.10 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 3.75 Million | 1.48 Million | 1.48 Million | 792.5 Thousand | 396.25 Thousand | 282.18 Thousand |
| Cost of Revenue | 32.13 Million | 93.12 Thousand | 93.12 Thousand | 13.6 Million | 25.23 Thousand | 34.14 Thousand |
| Gross Profit | -28.37 Million | 1.38 Million | 1.38 Million | -12.81 Million | 371.01 Thousand | 248.03 Thousand |
| Operating Expenses | 19.84 Million | 8.69 Million | 8.69 Million | 10.74 Million | 8.6 Million | 45.25 Million |
| Selling, General and Administrative Expenses | - | 7.89 Million | 7.89 Million | 8.67 Million | 6.01 Million | - |
| Research and Development Expenses | - | 792.57 Thousand | 792.57 Thousand | 2.06 Million | 1.03 Million | - |
| Other Expenses | - | - | - | - | - | 13.55 Million |
| Cost and Expenses | 51.97 Million | 8.78 Million | 8.78 Million | 24.34 Million | 8.62 Million | 45.28 Million |
| Operating Income | -48.22 Million | -7.3 Million | -7.3 Million | -23.55 Million | -11.77 Million | -31.13 Million |
| Interest Expense | 263.96 Thousand | 137.19 Thousand | - | 126.77 Thousand | - | 6502.00 |
| Income Tax Expense | -4.41 Million | 1258.00 | 1258.00 | -2.78 Million | 22.94 Thousand | 323.22 Thousand |
| Earnings before Tax | -40.39 Million | -10.18 Million | -10.18 Million | -18.39 Million | -7.78 Million | -31.13 Million |
| Net Income | -35.97 Million | -10.18 Million | -10.18 Million | -15.6 Million | -7.8 Million | -31.45 Million |
| Earnings Per Share Basic | - | -0.03 | -0.03 | -0.04 | -0.02 | - |
| Earnings Per Share Diluted | - | -0.03 | -0.03 | -0.04 | -0.02 | - |
| Weighted Average Shares Outstanding | 327.07 Million | 299.24 Million | 299.24 Million | 371.58 Million | 371.58 Million | 300.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 327.07 Million | 369.36 Million | 369.36 Million | 371.58 Million | 371.58 Million | 300.01 Million |
| Gross Margin | -7.56 | 0.94 | 0.94 | -16.17 | 0.94 | 0.88 |
| EBIT Margin | - | -7.49 | -7.49 | -27.81 | -28.46 | - |
| Profit Margin | -9.58 | -6.88 | -6.88 | -19.69 | -19.69 | -111.49 |
| EBITDA | - | -11.09 Million | -11.09 Million | -22.03 Million | -11.27 Million | - |
| Earnings Before Tax Margin | -12.84 | -4.93 | -4.93 | -29.72 | -29.72 | -110.32 |
XWEL
MANORAMA
TGRO
MAURY
VSSL
002913